MedPath

The effect of Berberis Vulgaris extract, on Cutaneous Leishmaniasis

Phase 3
Conditions
Cutaneous Leishmaniasis.
Cutaneous Leishmaniasis
Registration Number
IRCT2015060122512N1
Lead Sponsor
Mashhad University of Medical Sciences, Vice Chancellor for Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
120
Inclusion Criteria

Presence of cutaneous leishmaniasis with less than 6 months of clinical course; Not receive any treatment 3 months before; Age 8 years and above; Lesion diameter less than 3 cm; The number of lesion less than 5; The lesion on the limbs and trunk with the exception of joints’ surface.
Exclusion criteria: Pregnancy; Lactating; Receiving simultaneous treatment with other methods during treatment course; History of significance renal, Pulmonary and cardiovascular disease; Create a secondary infection of the wound; Deterioration of the condition of the patient during the study; Immune suppressor drugs consumption; Do not run commands therapy.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
esion size change. Timepoint: Weekly until 8 weeks. Method of measurement: Measuring the size of induration and ulcer by caliper.
Secondary Outcome Measures
NameTimeMethod
Side effects: erythema, itching. Timepoint: Weekly. Method of measurement: Clinical evaluation.
© Copyright 2025. All Rights Reserved by MedPath